Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | YTHDC1 | Q96MU7 | 11/20 | 0.63 |
| ▸ | PDE4A | P27815 | 4/20 | 0.57 |
| ▸ | PDE4B | Q07343 | 4/20 | 0.57 |
| ▸ | PDE4C | Q08493 | 4/20 | 0.57 |
| ▸ | PDE4D | Q08499 | 4/20 | 0.57 |
| ▸ | PDE5A | O76074 | 2/20 | 0.57 |
| ▸ | PDE1A | P54750 | 2/20 | 0.57 |
| ▸ | PDE1B | Q01064 | 2/20 | 0.57 |
| ▸ | PDE1C | Q14123 | 2/20 | 0.57 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.51 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.51 |
| ▸ | CNR2 | P34972 | 3/20 | 0.50 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9738420 | 0.89 | YTHDC1 (0.78) | YTHDC1 | |
| SCHEMBL9739828 | 0.88 | YTHDC1 (0.50) | YTHDC1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL9739343 | 0.87 | YTHDC1 (0.68) | YTHDC1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL9738444 | 0.87 | YTHDC1 (0.56) | YTHDC1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL9738428 | 0.85 | PDE4A (0.77) | YTHDC1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL9738081 | 0.85 | YTHDC1 (0.59) | YTHDC1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL9739040 | 0.85 | PDE4A (0.52) | YTHDC1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL9741179 | 0.79 | CCR4 (0.48) | YTHDC1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL9739440 | 0.77 | YTHDC1 (0.75) | YTHDC1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL27388375 | 0.77 | YTHDC1 (1.00) | YTHDC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0363320-A2 | Substituted 9H purine | CIBA-GEIGY AG (CH) | 1990-04-11 | — | — | EP | claimed |
| US-5110818-A | Antiepileptic agents | CIBA-GEIGY CORPORATION (US) | 1992-05-05 | — | — | US | disclosed |
| EP-0363320-A2 | Substituted 9H purine | CIBA-GEIGY AG (CH) | 1990-04-11 | — | — | EP | disclosed |